Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.53B |
| 2 |
NVIDIA
NVDA
|
+$1.07B |
| 3 |
Capital One
COF
|
+$1.02B |
| 4 |
Apple
AAPL
|
+$998M |
| 5 |
Amazon
AMZN
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$671M |
| 3 |
Coca-Cola
KO
|
+$501M |
| 4 |
Qualcomm
QCOM
|
+$435M |
| 5 |
Applovin
APP
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.45% |
| 2 | Financials | 14.05% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Capital Southwest
CSWC
$1.6B
| $248K | ﹤0.01% |
11,251
| – | – |
|
3802
Telomir Pharmaceuticals
TELO
$76.3M
| $246K | ﹤0.01% |
196,880
-232,372
| -54% | -$537K |
|
3803
Comscore
SCOR
$108M
| $246K | ﹤0.01% |
51,057
-432
| -0.8% | -$2.21K |
|
3804
ABVC BioPharma
ABVC
$25M
| $246K | ﹤0.01% |
110,499
+6,017
| +6% | +$8.19K |
|
3805
Aligos Therapeutics
ALGS
$43.7M
| $246K | ﹤0.01% |
34,048
+5,978
| +21% | +$35.8K |
|
3806
Drilling Tools International
DTI
$86.1M
| $244K | ﹤0.01% |
85,694
-134,054
| -61% | -$334K |
|
|
RBOT
3807
DELISTED
Vicarious Surgical
RBOT
| $243K | ﹤0.01% |
32,434
+631
| +2% | +$4.58K |
|
3808
Femasys
FEMY
$7.1M
| $243K | ﹤0.01% |
12,570
+295
| +2% | +$6.18K |
|
|
GGRP
3809
Glimpse Group
GGRP
$19.5M
| $242K | ﹤0.01% |
177,945
+2,268
| +1% | +$2.9K |
|
3810
Gray Media Inc
GTN.A
$612M
| $242K | ﹤0.01% |
22,227
+2,086
| +10% | +$16.7K |
|
|
NEUE
3811
DELISTED
NeueHealth
NEUE
| $241K | ﹤0.01% |
34,960
+24
| +0.1% | +$161 |
|
|
ARTV
3812
Artiva Biotherapeutics
ARTV
$564M
| $240K | ﹤0.01% |
159,041
-251,416
| -61% | -$528K |
|
3813
Woori Financial
WF
$17.1B
| $240K | ﹤0.01% |
+4,829
| New | +$191K |
|
3814
DarioHealth
DRIO
$72.9M
| $240K | ﹤0.01% |
17,917
-282
| -2% | -$3.91K |
|
|
RYM
3815
RYTHM Inc
RYM
$44.9M
| $239K | ﹤0.01% |
11,708
+289
| +3% | +$6.37K |
|
|
IGMS
3816
DELISTED
IGM Biosciences
IGMS
| $239K | ﹤0.01% |
213,273
-212,387
| -50% | -$259K |
|
3817
Oxbridge Re Holdings
OXBR
$9.64M
| $238K | ﹤0.01% |
136,984
+1,568
| +1% | +$2.61K |
|
3818
Cryo-Cell International
CCEL
$31.3M
| $238K | ﹤0.01% |
45,831
+601
| +1% | +$3.17K |
|
3819
Innoviz Technologies
INVZ
$114M
| $237K | ﹤0.01% |
144,534
+71,334
| +97% | +$62.3K |
|
3820
NeuroOne Medical Technologies
NMTC
$13.2M
| $237K | ﹤0.01% |
58,138
+475
| +0.8% | +$1.75K |
|
3821
Tempest Therapeutics
TPST
$19.3M
| $236K | ﹤0.01% |
34,736
+1,402
| +4% | +$9.97K |
|
|
KYNB
3822
Kyntra Bio
KYNB
$28.7M
| $233K | ﹤0.01% |
44,036
+856
| +2% | +$6.24K |
|
3823
Coffee Holding Co
JVA
$20.2M
| $232K | ﹤0.01% |
53,581
-695
| -1% | -$2.56K |
|
|
CHA
3824
Chagee Holdings Ltd
CHA
$1.91B
| $232K | ﹤0.01% |
+8,882
| New | +$272K |
|
|
GIFT
3825
Giftify Inc
GIFT
$31.9M
| $232K | ﹤0.01% |
154,458
+1,392
| +0.9% | +$2.37K |
|
Similar funds
Geode Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Geode Capital Management held 4,594 positions worth $1.43T, up 12% from $1.27T the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Geode Capital Management's Q2 2025 filing shows 119 new, 2,787 increased, 1,425 reduced and 150 closed positions. Its largest new stake was Emera Inc: 3,219,448 shares worth $152M. The largest sale was Discover Financial Services, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q2 2025 buy was Emera Inc: 3,219,448 shares worth $152M.
- Geode Capital Management added most to Microsoft in Q2 2025, an estimated $1.53B increase.
- Geode Capital Management's biggest Q2 2025 reduction was Palantir, cutting an estimated $671M.
- Geode Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $1.09B.
- Geode Capital Management's ten largest holdings make up 32% of its $1.43T portfolio in Q2 2025.
- Geode Capital Management opened 119 new positions and closed 150 in Q2 2025.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $1.43T.
Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.